WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City on Wednesday, November 18, 2009 at 11:00 a.m. Eastern Standard Time.
